Why Learning How to Chase Butterflies Matters: A Response to Recent Commentaries

Document Type: Correspondence

Authors

1 Department of Health Management, Evaluation and Policy, School of Public Health, University of Montreal, Montréal, QC, Canada

2 Institute of Public Health Research of University of Montreal (IRSPUM), Montréal, QC, Canada

3 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

Keywords

Main Subjects


My colleagues and I were honoured to have so many reputable scholars taking precious time to read our article1 and write three solid commentaries.2-4... (Read more...)

  1. Lehoux P, Miller F, Daudelin G, Denis J. Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies. Int J Health Policy Manag. 2017;6(9):509-518.
  2. Greenhalgh T, Fahy N, Shaw S. The bright elusive butterfly of value in health technology development: Comment on “Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies.” Int J Health Policy Manag. 2017; forthcoming. doi:10.15171/ijhpm.2017.65
  3. Buttigieg S, Van Hoof J. The conceptualization of value in the value proposition of new health technologies; Comment on “Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies.” Int J Health Policy Manag. 2017; forthcoming. doi:10.15171/ijhpm.2017.75
  4. Parvizi N, Parvizi S. New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.” Int J Health Policy Manag. 2017; forthcoming. doi:10.15171/ijhpm.2017.59
  5. Designing Responsible Innovation in Health: The In Fieri Research Program. http://infieri.umontreal.ca/en/home/.
  6. Nightingale P, Coad A. Muppets and Gazelles: Political and Methodological Biases in Entrepreneurship Research. Ind Corp Change. 2014;23(1):113-143.